Editorial: Signaling pathways behind immune evasion and therapy resistance

被引：0
|
作者：
Martin-Orozco, Elena [1 ]
Wang, Lisheng [2 ]
Chatterjee, Shilpak [3 ]
Hanks, Brent A. [4 ]
机构：
[1] Univ Murcia, Murcia BioHlth Res Inst, Murcia, Spain
[2] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada
[3] Indian Inst Chem Biol CSIR, Kolkata, India
[4] Duke Univ, Dept Med, Durham, NC USA
来源：
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
关键词：
tumor immunity; PD-L1; cAMP; UPR; PDE4B; N6-methyladenosine; UQCRC1; PDIA5; ADENOSINE;
D O I：
10.3389/fimmu.2022.1104167
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Editorial: Signaling Pathways in Embryonic Development
    Sanz-Ezquerro, Juan J.
    Munsterberg, Andrea E.
    Stricker, Sigmar
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2017, 5
  • [22] Overcoming Adaptive Therapy Resistance in AML By Targeting Immune Response Pathways
    Melgar, Katelyn M.
    Jones, LaQuita M.
    Walker, Mackenzie
    Bolanos, Lyndsey C.
    Hueneman, Kathleen
    Wunderlich, Mark
    Jiang, Jiang-Kang
    Wilson, Kelli
    Zhang, Xiaohu
    Sutter, Patrick
    Xu, Xin
    Choi, Kwangmin
    Tawa, Gregory
    Lorimer, Donald
    Abendroth, Jan
    O'Brien, Eric
    Hoyt, Scott
    Berman, Ellin
    Famulare, Christopher
    Mulloy, James C.
    Levine, Ross L.
    Rosenbaum, Jan S.
    Perentesis, John P.
    Thomas, Craig J.
    Starczynowski, Daniel T.
    BLOOD, 2019, 134
  • [23] Overcoming adaptive therapy resistance in AML by targeting immune response pathways
    Melgar, Katelyn
    Walker, Morgan M.
    Jones, LaQuita M.
    Bolanos, Lyndsey C.
    Hueneman, Kathleen
    Wunderlich, Mark
    Jiang, Jiang-Kang
    Wilson, Kelli M.
    Zhang, Xiaohu
    Sutter, Patrick
    Wang, Amy
    Xu, Xin
    Choi, Kwangmin
    Tawa, Gregory
    Lorimer, Donald
    Abendroth, Jan
    O'Brien, Eric
    Hoyt, Scott B.
    Berman, Ellin
    Famulare, Christopher A.
    Mulloy, James C.
    Levine, Ross L.
    Perentesis, John P.
    Thomas, Craig J.
    Starczynowski, Daniel T.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (508)
  • [24] Mechanisms of HIF1A-mediated immune evasion in gastric cancer and the impact on therapy resistance
    Qi, Hao
    Ma, Xiaoyu
    Ma, Yu
    Jia, Liuyu
    Liu, Kuncong
    Wang, Honghu
    CELL BIOLOGY AND TOXICOLOGY, 2024, 40 (01)
  • [25] Editorial: Immune evasion mechanisms and their role in the pathogenesis of autoimmune disorders
    Rizzo, Fabiana
    Houen, Gunnar
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [26] Editorial: Immune Evasion Strategies in Protozoan-Host Interactions
    Morrot, Alexandre
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [27] Autophagy in cancer development, immune evasion, and drug resistance
    Niu, Xuegang
    You, Qi
    Hou, Kaijian
    Tian, Yu
    Wei, Penghui
    Zhu, Yang
    Gao, Bin
    Ashrafizadeh, Milad
    Aref, Amir Reza
    Kalbasi, Alireza
    Canadas, Israel
    Sethi, Gautam
    Tergaonkar, Vinay
    Wang, Lingzhi
    Lin, Yuanxiang
    Kang, Dezhi
    Klionsky, Daniel J.
    DRUG RESISTANCE UPDATES, 2025, 78
  • [28] Circular RNAs: driving forces behind chemoresistance and immune evasion in bladder cancer
    Saadh, Mohamed J.
    Hussein, Wael Sheet
    Al-Hussainy, Ali Fawzi
    Bishoyi, Ashok Kumar
    Rekha, M. M.
    Kundlas, Mayank
    Kavitha, V.
    Aminov, Zafar
    Taher, Sada Ghalib
    Alwan, Mariem
    Jawad, Mahmood
    Mushtaq, Hiba
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [29] Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
    Zhang, Junjie
    Zhu, Lining
    Feng, Pinghui
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2014, (85):
  • [30] Macrophage Factor Xa Signaling Promotes Cancer Immune Evasion
    Graf, Claudine
    Wilgenbus, Petra
    Kitano, Maki
    Macher-Goeppinger, Stephan
    Ruf, Wolfram
    BLOOD, 2018, 132
12345